Welcome to the University of Toronto Early Stage Technology (UTEST) Program.

Learn More

Latest News

EBT Secures USD$10M Series A

EBT Medical, Inc., a 2018 UTEST company, is developing disruptive neuromodulation therapies for pelvic health disorders, recently secured a USD$10M Series A investment, co-led by two top-tier venture capital firms, SV Health Investors and Genesys Capital. EBT intends to use the funding to further develop its revolutionary noninvasive neuromodulation technology, as well as to pursue… Read more »

ODAIA RAISES $1.6 MILLION TO COMMERCIALIZE ITS PREDICTIVE AI PLATFORM

UTEST 2018 company, ODAIA an AI-powered software-as-a-service (SaaS) startup has raised $1.6 million in seed funding to help fuel its predictive customer analytics tool. The round as co-led by StandUp Ventures and Panache Ventures, which earlier today announced the final close of its Fund I. ODAIA’s seed round also saw participation from BDC Capital’s Women in Technology… Read more »

DEEP GENOMICS DISCOVERS GENETIC DISORDER TREATMENT DRUG VIA AI

Deep Genomics, UTEST cohort 2015, a Toronto-based AI therapeutics startup, has made the first-ever discovery of a diseases treatment and drug candidate using artificial intelligence. The startup announced on Wednesday that its propriety AI-based drug discovery platform has identified a novel treatment target and corresponding drug candidate for Wilson disease, a rare and potentially life-threatening… Read more »

GENE42 LAUNCH CANADA’S FIRST NATIONAL RARE DISEASE RESEARCH PLATFORM

Gene42, a UTEST company from the 2015 cohort, recently launched Genomics4RD, Canada’s first national rare disease research platform, in partnership with research association Care4Rare. Care4Rare and Gene42 built Genomics4RD as part of a national initiative funded by Genome Canada. The project is focused on employing multi-omics, an approach to biological analysis, to deliver diagnostic care for rare genetic… Read more »

AmacaThera raises $3.25M

AmacaThera a UTEST company from 2015, has raised $3.25 million to develop a gel-based drug delivery system that could eliminate the need to give patients powerful painkillers following surgery – a key source of the current opioid crisis. The startup, AmacaThera, is built on a gel technology developed in the U of T lab of Molly Shoichet, Ontario’s… Read more »

BLUE J LEGAL RAISES $9.3 MILLION

UTEST company (cohort 2015), Blue J Legal has raised $9.3 million CAD in a series A round. The round was led by Relay Ventures, with participation from US-based LDV Partners, and returning investors BDC Capital and Mistral Venture Partners. Mistral made an undisclosed investment Blue J Legal in May 2017, though at the time the firm said it… Read more »

Silanna Group acquires Appulse Power!

    Appulse Power Inc., a UTEST company from 2014,  founded by U of T Engineering alumni Ahsan Zaman, Behzad Mahdavikhah, Aleksandar Radić, and Professor Aleksandar Prodić has been acquired by the multinational Silanna Semiconductor for an undisclosed amount. “The success of Appulse is credit to the incredible talent and dedication of my three co-founders,” says Professor Prodić. “This team has brought us… Read more »

Portfolio

Would you like to know more?

Hassan Jaferi
Co-director, UTEST
hjaferi@tiap.ca
Kurtis Scissons
Co-director, UTEST
kurtis.scissons@utoronto.ca

Connect with Us